Immix Biopharma, Inc.
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
IMMX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11400 WEST OLYMPIC BLVD., 90064 LOS ANGELES
- Website:
- https://immixbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing advanced cell therapies. The company's primary focus is on pioneering treatments for AL Amyloidosis, hematologic malignancies, and other serious diseases with unmet medical needs. A core part of its strategy is to overcome the challenge of neurotoxicity, a significant side effect that currently limits the widespread adoption of Chimeric Antigen Receptor T-cell (CAR-T) therapies. By developing safer cell therapies, ImmixBio aims to expand treatment accessibility to a broader patient population and enable administration in a greater number of medical centers. The company collaborates with industry leaders to accelerate its research and development efforts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Immix Biopharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immix Biopharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immix Biopharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
